Tempus announces multi-year collaboration with Moderna, Merck
Tempus said it expanded a multi-year collaboration with Moderna and Merck to support potential commercialization of intismeran autogene. Tempus will manage tissue and blood sample collection and may provide next-generation sequencing services, with financial terms undisclosed.